Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS

Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS

Background: The high heterogeneity of acute respiratory distress syndrome (ARDS) contributes to paradoxical conclusions from previous investigations of rosuvastatin for ARDS. Identification of the population (phenotype) that could benefit from rosuvastatin is a novel exploration for the precise trea...

Full description

Bibliographic Details
Main Authors: Shi Zhang, Zhonghua Lu, Zongsheng Wu, Jianfeng Xie, Yi Yang, Haibo Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Medicine
Subjects:
ARDS
Rosuvastatin
heterogeneity
machine learning
precise treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.598621/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.598621/full

Similar Items